Working as a leading Canadian pharmaceutical and cannabis firm, Tilray has released a chain of tweets on its official Twitter handle to announce the crucial decisions taken by the team in the light of the COVID-19 outbreak. The firm has halted all non-essential company traveling, including domestic as well as international flights, conference and meetings. Tilray is adamant about keeping the health, safety, and well-being of its workforce and the partner communities as a priority and so has taken the strategic step.
Tilray paused all non-essential company travel including domestic and international flights, conference and meeting attendance. Employees who are able to are encouraged to work from home as a preventative measure as guided by federal governments to reduce the spread of infection.
— Tilray (@tilray) March 13, 2020
In its tweet, Tilray has urged its employees to opt for work from home facility to ensure minimum human gathering. The reports suggest that getting in contact with an infected person is one of the prime reasons for the transmission of the disease. Owing to this, governments and business entities around the world are encouraging people to avoid social interaction and human contact, especially in huge gatherings and events such as conferences, seminars, or parties. Corona has posed a severe threat to the world population and has been responsible for deaths at an alarming rate. The disease has been declared as a pandemic by the World Health Organization and this indicates the severity of the threat it has imposed upon us.
We will continue to prioritize the health, safety and well-being of our workforce and the people in the communities where we operate.
— Tilray (@tilray) March 13, 2020
Tilray has affirmed that they are monitoring COVID-19 closely and are following the guidance and warnings of the government organizations diligently on a global as well as on a regional scale. The firm has encouraged its employees to take all the necessary precautionary measures and follow a healthy work and personal regime.
Based in Canada, Tilray takes pride in being the first GMP-certified medical cannabis producer to supply cannabis flowers and extracts. It is incorporated in the United States with chief operational offices headquartered in Toronto, Ontario. The firm is quite popular for being engaged in the research, cultivation, production, and distribution of medical cannabis and cannabinoids.
